Presentation is loading. Please wait.

Presentation is loading. Please wait.

EBMT Activity Survey Teams 39,313 Patients 43,636 Transplants

Similar presentations


Presentation on theme: "EBMT Activity Survey Teams 39,313 Patients 43,636 Transplants"— Presentation transcript:

1 EBMT Activity Survey 2016 679 Teams 39,313 Patients 43,636 Transplants
49 Countries For internal use only. For any other use, please contact Helen Baldomero for permission:

2 EBMT Activity Survey in 2016: Patient and transplant numbers
Allogeneic HSCT Autologous Total 1st allo/1st auto HSCT Additional HSCT TOTAL Teams: 679 (of 707) Countries reporting: 49 16,507 1,134 17,641 22,806 3,189 25,995 39,313 4,323 43,636 Indication

3 EBMT Activity Survey in 2016: Donor type and stem cell source: all transplants
PBSC HLA-id sibling Haplo-identical Other family Syngeneic Unrelated Allogeneic Autologous 1,432 693 122 n.a. 1,452 3,699 98 5,977 2,306 341 24 8,993 17,641 25,995 Total 4,503 1,613 214 7,151 13,481 25,896 Donor type Stem Cell Source Cord 42 5 390 437 1

4 EBMT Activity Survey 2016: Main indications Allogeneic 1st HSCT
Autologous Total Leukemia Lymphoma Plasma cell disorder Solid tumor Non-malignant disorders Bone marrow failure Other Total Patients 12,116 1,648 463 33 2,087 894 160 16,507 464 8,543 11,931 1,483 372 5 13 22,806 12,580 10,191 12,394 1,516 2,459 899 173 39,313 Indication

5 Allogeneic HSCT in Europe 2016 1st HSCT
(early AML 21%, advanced AML 11%, transformed AML 6%) J.R. Passweg et al, Bone Marrow Transplantation, Jan 2018

6 Autologous HSCT in Europe 2016 1st HSCT
J.R. Passweg et al, Bone Marrow Transplantation, Jan 2018

7 HSCT Activity in Europe 1990-2016: Transplant type 1st HSCT
58% 42% J.R. Passweg et al, Bone Marrow Transplantation, Jan 2018

8 HSCT Activity in Europe 1990-2016: donor origin: 1st. HSCT
J.R. Passweg et al, Bone Marrow Transplantation , Jan 2018

9 HSCT Activity in Europe 1990-2016: Main indications: allogeneic 1st
HSCT Activity in Europe : Main indications: allogeneic 1st. HSCT

10 HSCT Activity in Europe 1990-2016: Main indications: autologous 1st
HSCT Activity in Europe : Main indications: autologous 1st. HSCT

11 HSCT - rates in Europe 2016 N. allogeneic transplants
0 or no report 151 – 200 201 – 300 > 300 Algeria, Iran, Iraq, Jordan, Kazakhstan, Lebanon, South Africa, Tunisia Saudi Arabia Israel N. allogeneic transplants per 10 million inhabitants J.R. Passweg et al, Bone Marrow Transplantation, Jan 2018

12 HSCT - rates in Europe 2016 N. autologous transplants
per 10 million inhabitants 0 or no report 301 – 400 401 – 500 > 500 Algeria, Iran, Iraq, Jordan, Kazakhstan, Lebanon, Saudi Arabia, South Africa, Tunisia Israel J.R. Passweg et al, Bone Marrow Transplantation, Jan 2018


Download ppt "EBMT Activity Survey Teams 39,313 Patients 43,636 Transplants"

Similar presentations


Ads by Google